Overview

Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the safety of IW-9179 in patients with diabetic gastroparesis (DGP) and the effect of treatment on the cardinal symptoms of DGP.
Phase:
Phase 2
Details
Lead Sponsor:
Ironwood Pharmaceuticals, Inc.